DE69637807D1 - Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen - Google Patents

Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen

Info

Publication number
DE69637807D1
DE69637807D1 DE69637807T DE69637807T DE69637807D1 DE 69637807 D1 DE69637807 D1 DE 69637807D1 DE 69637807 T DE69637807 T DE 69637807T DE 69637807 T DE69637807 T DE 69637807T DE 69637807 D1 DE69637807 D1 DE 69637807D1
Authority
DE
Germany
Prior art keywords
recombinant
vaccine
livestine
belly
cats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637807T
Other languages
English (en)
Inventor
Jean-Christophe Francis Audonnet
Philippe Guy Baudu
Michel Albert Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS filed Critical Merial SAS
Application granted granted Critical
Publication of DE69637807D1 publication Critical patent/DE69637807D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69637807T 1995-11-30 1996-11-19 Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen Expired - Lifetime DE69637807D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514450A FR2741806B1 (fr) 1995-11-30 1995-11-30 Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
PCT/FR1996/001830 WO1997020059A1 (fr) 1995-11-30 1996-11-19 Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline

Publications (1)

Publication Number Publication Date
DE69637807D1 true DE69637807D1 (de) 2009-02-26

Family

ID=9485221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637807T Expired - Lifetime DE69637807D1 (de) 1995-11-30 1996-11-19 Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen

Country Status (15)

Country Link
US (2) US6074649A (de)
EP (1) EP0870046B1 (de)
JP (2) JP3972218B2 (de)
AT (1) ATE420190T1 (de)
AU (1) AU725846B2 (de)
BR (1) BR9611845A (de)
CA (1) CA2239072C (de)
DE (1) DE69637807D1 (de)
DK (1) DK0870046T3 (de)
ES (1) ES2320938T3 (de)
FR (1) FR2741806B1 (de)
NZ (1) NZ322526A (de)
PT (1) PT870046E (de)
WO (1) WO1997020059A1 (de)
ZA (1) ZA969951B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002112770A (ja) 2000-10-05 2002-04-16 Kyoritsu Seiyaku Kk 新規組換えネコヘルペスウイルス１型およびこれを用いた多価ワクチン
US20040241723A1 (en) * 2002-03-18 2004-12-02 Marquess Foley Leigh Shaw Systems and methods for improving protein and milk production of dairy herds
EP1606419A1 (de) 2003-03-18 2005-12-21 Quantum Genetics Ireland Limited Systeme und methoden zur erhohung der milchproduktion in tieren
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
US8541003B2 (en) 2003-06-20 2013-09-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
MXPA06009452A (es) 2004-02-19 2007-03-15 Univ Alberta Polimorfismos del promotor de leptin y sus usos.
PT1881845E (pt) 2005-04-25 2010-05-31 Merial Ltd Vacinas de vírus nipah
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
EP2186823A1 (de) 2005-11-14 2010-05-19 Merial Limited Gentherapie für Nierenversagen
US7790203B2 (en) * 2005-12-13 2010-09-07 Lowder Tom R Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
WO2009051823A2 (en) * 2007-10-18 2009-04-23 Michigan State University Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof
CN103585643A (zh) 2009-04-03 2014-02-19 梅里亚有限公司 运载新城疫病毒的禽疫苗
WO2012030720A1 (en) 2010-08-31 2012-03-08 Merial Limited Newcastle disease virus vectored herpesvirus vaccines
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
EP2694677A2 (de) 2011-04-04 2014-02-12 Netherland Cancer Institute Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung mit proteinkinasehemmern
AU2012240246A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
WO2012145577A1 (en) 2011-04-20 2012-10-26 Merial Limited Adjuvanted rabies vaccine with improved viscosity profile
WO2012149038A1 (en) 2011-04-25 2012-11-01 Advanced Bioscience Laboratories, Inc. Truncated hiv envelope proteins (env), methods and compositions related thereto
WO2012166493A1 (en) 2011-06-01 2012-12-06 Merial Limited Needle-free administration of prrsv vaccines
WO2013025274A1 (en) 2011-08-12 2013-02-21 Merial Limited Vacuum -assisted preservation of biological products, in particular of vaccines
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
EP2968514A1 (de) 2013-03-12 2016-01-20 Merial, Inc. Mittels reverser genetik hergestellte impfstoffzusammensetzungen gegen schmallenberg-virus und verfahren zur verwendung davon
EP3215188A1 (de) 2014-11-03 2017-09-13 Merial, Inc. Verfahren zur verwendung von mikronadelimpfstoffformulierungen zur anregung von schützender immunität gegen das tollwutvirus bei tieren
MX2017016895A (es) 2015-06-23 2018-04-10 Merial Inc Vectores virales recombinantes que contienen la proteina menor del virus del sindrome reproductor y respiratorio porcino (prrsv) y sus metodos de elaboracion y uso.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68924916T2 (de) * 1988-08-08 1996-05-15 Cetus Oncology Corp Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns.
WO1991001332A1 (en) * 1989-07-21 1991-02-07 The Upjohn Company Feline calicivirus capsid protein and nucleotide sequence
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
ES2188589T3 (es) * 1992-06-26 2003-07-01 Akzo Nobel Nv Vacuna recombinante del herpes virus felino.
EP0606452B1 (de) * 1992-07-30 2002-11-13 Akzo Nobel N.V. Impfstoff-vektoren von rekombinantem katzen-herpesvirus
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
JPH09512177A (ja) * 1994-04-29 1997-12-09 ファルマシア・アンド・アップジョン・カンパニー ネコ免疫不全ウイルスワクチン

Also Published As

Publication number Publication date
JP2000501927A (ja) 2000-02-22
PT870046E (pt) 2009-04-13
US6387376B1 (en) 2002-05-14
NZ322526A (en) 2000-07-28
FR2741806A1 (fr) 1997-06-06
US6074649A (en) 2000-06-13
AU7630196A (en) 1997-06-19
CA2239072A1 (en) 1997-06-05
EP0870046B1 (de) 2009-01-07
ES2320938T3 (es) 2009-05-29
FR2741806B1 (fr) 1998-02-20
CA2239072C (en) 2012-04-24
BR9611845A (pt) 1999-03-09
JP2006320337A (ja) 2006-11-30
EP0870046A1 (de) 1998-10-14
DK0870046T3 (da) 2009-05-11
ZA969951B (en) 1998-05-27
WO1997020059A1 (fr) 1997-06-05
ATE420190T1 (de) 2009-01-15
JP3972218B2 (ja) 2007-09-05
AU725846B2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
DE69637807D1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
TR199901179T2 (xx) Lepidopterana kar�� aktif olan delta-endotoksinleri eksprese eden transjenik bitkiler.
MX6339E (es) Metodo para elaborar dentro de un huesped bacteriano y excretar a traves de la membrana de la celula huesped,una proteina o un polipeptido seleccionados
DE69737058D1 (de) Rekombinante hunde-herpesviren
MX9202512A (es) Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.
BR9809516A (pt) Proteìnas com atividades inseticidas e método de uso
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
PT652287E (pt) Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
ATE270328T1 (de) Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können
ATE319819T1 (de) Humane hirn-spezifische carboxypeptidase b
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
EP0960937A4 (de) Neues semaphorin-gen: semaphorin y
RU95107705A (ru) Полипептид, рекомбинантный полинуклеотид, вакцина, применение вакцины
ATE323767T1 (de) Impfstoff für die infektiöse peritonitis der katzen
BR9406536A (pt) Segmento de DNA que compreende gene codificador de proteína inseticida
BR9812066A (pt) Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação
BR0110867A (pt) Toxinas
PT84474B (pt) Processo para a preparacao de uma substancia proteica insecticida
PT839913E (pt) Metodo de expressao de polipeptidos em peixe por imerssao numa solucao de adn plasmidico
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition